Among the companies listed on the Shanghai Stock Exchange and the Shenzhen Stock Exchange, there are a total of 35 medical devices and 8 companies listed on the Hong Kong Stock Exchange. Medical devices, medicines, and medical services are also known as the troika of the medical industry . The support of national policies and the expansion of market capacity have undoubtedly made the medical device industry once again a hotspot for the medical industry. Industry experts predict that the current total output value of medical devices in China is more than 5% in the world medical device market. It is estimated that by 2021, the total output value of medical devices in China will be close to 500 billion yuan. Among the companies listed on the Shanghai Stock Exchange and the Shenzhen Stock Exchange, there are a total of 35 medical devices and 8 companies listed on the Hong Kong Stock Exchange. Faced with such a huge industry, this paper selects 43 medical device listed companies as research objects, and analyzes the three aspects of the company's positioning, basic situation and financial report, trying to tell everyone about the current status of the industry. 1. Kehua Bio: a leading enterprise in the domestic in vitro clinical diagnosis (IVD) industry Basic situation: Kehua Biological was established on November 23, 1981, and listed on the Shenzhen Stock Exchange on July 21, 2004. The chairman of the board is Tang Weiguo. The company's main business is the research, production and sales of in vitro clinical immunodiagnostic reagents, in vitro clinical chemistry diagnostic reagents. Financial Report: According to the first half of 2016, Kehua Biotech reported that Shanghai Kehua Bio-engineering Co., Ltd. achieved operating income of 690 million yuan in the first half of 2016, an increase of 19.06% over the same period of the previous year; net profit attributable to the parent company. It was 138 million yuan, an increase of 10.46% over the same period of the previous year. 2. Daan Gene: a leading company in the industrial chain layout of molecular diagnostics in China Basic situation: Daan Gene was established on August 17, 1988, and listed on the Shenzhen Stock Exchange on August 9, 2004. The company's main business is reagents, services and instruments. Financial report: According to the “Daan Gene†financial report for the first half of 2016, the operating income of Sun Yat-sen University’s Daan Gene Co., Ltd. in the first half of 2016 reached 789 million yuan, an increase of 25.81% over the same period of the previous year; the net profit was 64 million yuan. Compared with the same period last year, it increased by 6.64%. Dental Machine,Dental Equipment,Dental Instruments,Portable Dental Unit ZHEJIANG FOMOS MEDICAL TECHNOLOGY CO.,LTD. , https://www.ifomos.com.jpg)
.jpg)
.jpg)